ANI | Updated: Nov 17, 2021 10:23 IST
Mumbai (Maharashtra) [India], November 17 (ANI): On World COPD Day, India’s first pneumotach-based portable wireless spirometer to diagnose Chronic Obstructive Pulmonary Disorder (COPD) and asthma was launched by pharmaceutical major Cipla.
According to Cipla, ‘Spirofy’ is a wireless device with good battery backup, making it suitable for use in outdoor camps, remote areas with power shortages. The advanced device ensures high result accuracy and individual patient safety using bacterial viral filters. The company developed the device after five years of in-house research.
The device generates reports in real-time, which can be printed using a portable wireless thermal printer instantly, or a pdf version can be shared on the phone.
Speaking on the launch, Umang Vohra, MD and CEO, Cipla Limited said, “Cipla has been steadfastly focused on addressing the world’s growing respiratory disease burden, and with this launch, we see ourselves steadily advancing to combat chronic respiratory ailments like COPD. The Spirofy launch aims to help doctors across the country to improve lives of patients through accurate and affordable diagnosis.”
Cipla will undertake the training of physicians in the interpretation of spirometry results.
“Spirometry is the gold standard for COPD diagnosis, however owing to the bulky size, complex functionality, need for regular maintenance are some reasons that impacted the widespread acceptance of conventional spirometers by medical practitioners. This resulted in underdiagnosis or misdiagnosis of COPD cases in India. Currently, COPD remains the second most common cause of death in India after heart diseases, where India alone bears 32 per cent of the global COPD burden,” reads the company statement. (ANI)
spirometer
COPD
Asthma
Cipla
Air pollution may lead to severe COVID cases, says AIIMS director Randeep Guleria
Updated: Oct 04, 2021 14:51 IST
Eli Lilly, Cipla enter in partnership to enhance access to Lilly's key diabetes products
Updated: Sep 01, 2021 20:14 IST
29.3 pc adolescents in Delhi have asthma linked to air pollution
Updated: Jun 29, 2021 13:52 IST
Cipla seeks DCGI nod for import of Moderna's COVID-19 vaccine: Sources
Updated: May 24, 2021 19:15 IST
COVID antibody cocktail used to treat Donald Trump now launched in India
Updated: Oct 19, 2020 03:20 IST
With dip in air quality in Delhi, health experts witness 15 pc rise in COPD/Asthma cases
Updated: Jul 20, 2020 23:01 IST
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir for 'restricted emergency use'
copyrights © aninews.in | All rights Reserved
